We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Immune checkpoint inhibitors and dermatologic procedures: a retrospective review of postoperative complications.
- Authors
Puza, Charles J.; Pyle, Hunter J.; Srivastava, Divya; Nijhawan, Rajiv I.
- Abstract
In 2011, with ipilimumab, immune checkpoint inhibitors (ICI) gained FDA approval for the treatment of metastatic melanoma [[4]]. Collected variables included patient demographics, ICI indication, surgery indication, postoperative course including complications, and length of follow-up. Results here suggest that ICI therapy does not substantially increase the rate of complications in patients undergoing dermatologic procedures [[2]].
- Subjects
IMMUNE checkpoint inhibitors; SURGICAL complications; MOHS surgery; RETROSPECTIVE studies; RENAL cell carcinoma; CURETTAGE; IMMUNOTHERAPY
- Publication
Archives of Dermatological Research, 2023, Vol 315, Issue 10, p2941
- ISSN
0340-3696
- Publication type
Article
- DOI
10.1007/s00403-023-02701-7